Literature DB >> 10404505

Transthoracic needle aspiration biopsy: value in the diagnosis of mycobacterial lung opacities.

J Ferreirós1, A Bustos, S Merino, E Castro, M Dorao, C Crespo.   

Abstract

The purpose of this study was to assess the value of transthoracic fine-needle aspiration in the diagnosis of mycobacterial infection as the cause of focal lung opacities. Six hundred twelve fine-needle aspiration biopsies were performed from 1985 to 1997 in 587 patients with solitary or multiple lung opacities. Initial procedures, including sputum analysis and bronchoscopy, had been nondiagnostic. Fluoroscopic or computed tomography guidance was used, and a pathologist was present. A diagnosis of mycobacterial infection was established when acid-fast bacilli were demonstrated in the aspirate. In 487 patients, a malignant cause was confirmed, and six other patients had carcinoid tumor. Of 94 nonmalignant opacities, 24 (26%) were determined to have a mycobacterial cause. Fine-needle aspiration biopsy detected acid-fast bacilli in 15 of 24 cases (sensitivity, 62.5%; specificity, 100%). Radiologic findings included upper lobe involvement (17 of 24 cases), single opacities (12 of 24 cases), satellite nodules (4 of 12 cases with single opacities), irregular borders (19 of 24), eccentric calcification (2 of 24), and cavitation (8 of 24). The authors conclude that fine-needle aspiration biopsy must be processed for acid-fast bacilli when nonmalignant cytologic findings result, even if the results of sputum smears, cultures, and bronchoscopy are negative.

Entities:  

Mesh:

Year:  1999        PMID: 10404505

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  1 in total

1.  Pulmonary Tuberculosis Confirmed by Percutaneous Transthoracic Needle Biopsy: Analysis of CT Findings and Review of Correlations with Underlying Lung Disease.

Authors:  Ji Young Choo; Ki Yeol Lee; Mi-Young Kim; Eun-Young Kang; Yu Whan Oh; Seung Hwa Lee; Bo Kyung Seo; Bo Kyung Je
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.